RebiQoL: A randomized trial of telemedicine patient support program for health-related quality of life and adherence in people with MS treated with Rebif

RebiQoL was a phase IV multicenter randomized study to assess the impact of a telemedicine patient support program (MSP) on health-related quality of life (HRQoL) in patients with relapsing-remitting MS (RRMS) being administered with Rebif with the RebiSmart device. The primary endpoint was to asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Landtblom, Anne-Marie, Guala, Dimitri, Martin, Claes, Olsson-Hau, Stefan, Haghighi, Sara, Jansson, Lillemor, Fredrikson, Sten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611587/
https://www.ncbi.nlm.nih.gov/pubmed/31276502
http://dx.doi.org/10.1371/journal.pone.0218453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611587/
https://www.ncbi.nlm.nih.gov/pubmed/31276502
http://dx.doi.org/10.1371/journal.pone.0218453

Ejemplares similares